GlassScriptPhysician profile
Peter J Clothier
NPI 1770564007
$490.21
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $68.62.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $169.85 | 2019 | |
| Glaxosmithkline, LLC. | $62.22 | 2019 | |
| Merck Sharp & Dohme LLC | $44.15 | 2019 | |
| Allergan, INC. | $29.74 | 2020 | |
| Si-Bone, INC. | $29.38 | 2019 | |
| Hologic Sales and Service, LLC | $26.71 | 2019 | |
| Abbvie INC. | $23.72 | 2019 | |
| Nevro Corp. | $19.97 | 2020 | |
| Ibsa Pharma INC. | $18.91 | 2020 | |
| Novo Nordisk INC | $16.46 | 2019 | |
| Genentech USA, INC. | $15.09 | 2019 | |
| Amgen INC. | $11.86 | 2019 | |
| Hikma Pharmaceuticals USA | $11.33 | 2019 | |
| Phadia US INC. | $10.82 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Clothier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.